Stroke, Vol 19, 693-699, Copyright © 1988 by American Heart Association
PM Kochanek, AJ Dutka, KK Kumaroo and JM Hallenbeck
Seven anesthetized dogs treated with prostaglandin I2, indomethacin, and
heparin were compared with 12 controls to test the hypothesis that the
salutary effect of treatment on recovery of neuronal function and cerebral
blood flow (CBF) after ischemia is coupled to the inhibition of platelet
accumulation. In this model of right hemisphere multifocal ischemia,
cortical somatosensory evoked response (CSER) amplitude, 14C
autoradiographic blood flow, and 111In-labeled platelet accumulation were
measured. The ratio of injured to noninjured hemispheric 111In activity
(cpm/g) provided an index of platelet accumulation. Treatment improved CBF
of the injured hemisphere compared with control after 4 hours of
reperfusion (74 +/- 17 versus 53 +/- 13 ml/100 g/min, p less than 0.05),
and it enhanced recovery of CSER amplitude (percent of baseline) after 1
hour of reperfusion compared with control (27.1 +/- 4.7% [treatment] versus
15.5 +/- 2.8% [control], p less than 0.05). However, the effect on CSER was
not sustained after 4 hours of recovery. Despite these effects on CSER and
CBF, treatment failed to inhibit 111In-labeled platelet accumulation in the
injured hemisphere (1.7 +/- 0.3% [treatment] versus 1.5 +/- 0.1% [control],
p greater than 0.05). Platelets may adhere to damaged endothelium despite
aggressive platelet antiaggregant therapy.
ARTICLES
Effects of prostacyclin, indomethacin, and heparin on cerebral blood flow and platelet adhesion after multifocal ischemia of canine brain
Diving Medicine Department, Naval Medical Research Institute, Bethesda, MD 20814-5055.
This article has been cited by other articles:
![]() |
J. M. Silakova, J. A. Hewett, and S. J. Hewett Naproxen Reduces Excitotoxic Neurodegeneration in Vivo with an Extended Therapeutic Window J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1060 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Morris, L. Zhang, Z. G. Zhang, M. Lu, K. L. Berens, P. M. Brown, and M. Chopp Extension of the Therapeutic Window for Recombinant Tissue Plasminogen Activator With Argatroban in a Rat Model of Embolic Stroke Stroke, November 1, 2001; 32(11): 2635 - 2640. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Najarian, P. Hardy, X. Hou, J. Lachapelle, A. Doke, F. Gobeil Jr., M.-S. Roy, P. Lachapelle, D. R. Varma, and S. Chemtob Preservation of neural function in the perinate by high PGE2 levels acting via EP2 receptors J Appl Physiol, August 1, 2000; 89(2): 777 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Soga, H. Fujita, T. Andoh, and F. Okumura Retinal Artery Air Embolism in Dogs: Fluorescein Angiographic Evaluation of Effects of Hypotension and Hemodilution Anesth. Analg., May 1, 1999; 88(5): 1004 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Choudhri, B. L. Hoh, R. A. Solomon, E. S. Connolly Jr, and D. J. Pinsky Use of a Spectrophotometric Hemoglobin Assay to Objectively Quantify Intracerebral Hemorrhage in Mice Stroke, November 1, 1997; 28(11): 2296 - 2302. [Abstract] [Full Text] |
||||
![]() |
K. H. Ryu, B. J. Hindman, D. K. Reasoner, and F. Dexter Heparin Reduces Neurological Impairment After Cerebral Arterial Air Embolism in the Rabbit Stroke, February 1, 1996; 27(2): 303 - 310. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |